OUR VisioN
A future where metastatic cancer is understood, targeted, and treatable for every patient.
OUR MISSION
At Metsystem, our mission is to advance the fight against metastatic cancer by personalizing care for patients with solid tumors. By harnessing cutting-edge technologies like patient-derived organoids, AI-powered image analysis, and metastasis-targeting drug screens, we empower oncologists to tailor treatment to the individual. Through close collaboration with clinicians, researchers, and innovators, we are creating new possibilities to improve patient outcomes, survival rates and quality of life for patients worldwide.
Our Founder Team
Ninna Struck Rossen
Chief Executive Officer
Kamilla Westarp Zornhagen
Chief Technological Officer
Silja Heilmann
Chief A.I Officer
“We believe that the challenges of beating cancer calls for open, dedicated, interdisciplinary collaboration.
We are truly priviliged to have had such generous partners and advisors on our journey so far, ranging from from clinicians, pathologists, bioinformaticians, researchers creating drug screens and biobanks, to automation engineers and image analysists.
”
– 2024 Demo Day at the Bio Innovation Institute.